A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease

• Main Authors: Mahmoud H Mosli, Othman Al-Harbi, Brian G Feagan, Majid A Almadi
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2015-01-01
• Series: The Saudi Journal of Gastroenterology
• Subjects: Crohn’s disease; inflammatory bowel disease; position statement; Saudi Gastroenterology Association; TNF antagonists; ulcerative colitis
• Online Access: http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=4;spage=185;epage=197;aulast=Mosli
• ISSN: 1319-3767; 1998-4049

The objective of this position statement from the Saudi Gastroenterology Association is to guide gastroenterologists on the use of tumor necrosis factor-alfa (TNF-α) antagonists for the treatment of the idiopathic inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis. In this article, we summarize the relevant literature regarding the safety and efficacy of TNF-α antagonists, highlight relevant safety concerns specific to the environment in Saudi Arabia, and provide specific recommendations for the use of these agents.